Envoy Medical (COCH) Operating Expenses (2021 - 2026)

Envoy Medical (COCH) has 6 years of Operating Expenses data on file, last reported at -$1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses fell 131.09% year-over-year to -$1.6 million; the trailing twelve-month figure through Mar 2026 stood at $15.8 million (down 19.99% YoY), and the FY2025 full-year result was $22.5 million, up 15.55% from the prior year.
• Operating Expenses fell to -$1.6 million in Q1 2026, from $6.5 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $6.8 million in Q4 2023 to a low of -$1.6 million in Q1 2026.
• A 5-year average of $3.7 million and a median of $4.5 million in 2023 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses surged 404.02% in 2023 and slumped 131.09% in 2026, its largest moves.
• Tracing COCH's Operating Expenses over 5 years: stood at $2.9 million in 2022, then surged by 133.01% to $6.8 million in 2023, then tumbled by 32.66% to $4.6 million in 2024, then soared by 40.71% to $6.5 million in 2025, then plunged by 124.8% to -$1.6 million in 2026.
• Business Quant data shows COCH's Operating Expenses at -$1.6 million in Q1 2026, $6.5 million in Q4 2025, and $5.8 million in Q3 2025.